Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2006 Apr;3(4):e91.
doi: 10.1371/journal.pmed.0030091. Epub 2006 Mar 7.

Five glutathione s-transferase gene variants in 23,452 cases of lung cancer and 30,397 controls: meta-analysis of 130 studies

Affiliations
Meta-Analysis

Five glutathione s-transferase gene variants in 23,452 cases of lung cancer and 30,397 controls: meta-analysis of 130 studies

Zheng Ye et al. PLoS Med. 2006 Apr.

Abstract

Background: Glutathione S-transferases (GSTs) are known to abolish or reduce the activities of intracellular enzymes that help detoxify environmental carcinogens, such as those found in tobacco smoke. It has been suggested that polymorphisms in the GST genes are risk factors for lung cancer, but a large number of studies have reported apparently conflicting results.

Methods and findings: Literature-based meta-analysis was supplemented by tabular data from investigators of all relevant studies of five GST polymorphisms (GSTM1 null, GSTT1 null, I105V, and A114V polymorphisms in the GSTP1 genes, and GSTM3 intron 6 polymorphism) available before August, 2005, with investigation of potential sources of heterogeneity. Included in the present meta-analysis were 130 studies, involving a total of 23,452 lung cancer cases and 30,397 controls. In a combined analysis, the relative risks for lung cancer of the GSTM1 null and GSTT1 null polymorphisms were 1.18 (95% confidence interval [CI]: 1.14-1.23) and 1.09 (95% CI: 1.02-1.16), respectively, but in the larger studies they were only 1.04 (95% CI: 0.95-1.14) and 0.99 (95% CI: 0.86-1.11), respectively. In addition to size of study, ethnic background was a significant source of heterogeneity among studies of the GSTM1 null genotype, with possibly weaker associations in studies of individuals of European continental ancestry. Combined analyses of studies of the 105V, 114V, and GSTM3*B variants showed no significant overall associations with lung cancer, yielding per-allele relative risks of 1.04 (95% CI: 0.99-1.09), 1.15 (95% CI: 0.95-1.39), and 1.05 (95% CI: 0.89-1.23), respectively.

Conclusions: The risk of lung cancer is not strongly associated with the I105V and A114V polymorphisms in the GSTP1 gene or with GSTM3 intron 6 polymorphism. Given the non-significant associations in the larger studies, the relevance of the weakly positive overall associations with the GSTM1 null and the GSTT1 null polymorphisms is uncertain. As lung cancer has important environmental causes, understanding any genetic contribution to it in general populations will require the conduct of particularly large and comprehensive studies.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Meta-Analyses of Studies of Lung Cancer and Five GST Gene Polymorphisms ( GSTM1 null, GSTT1 null, and GSTP1 I105V, GSTP1 A114V, and GSTM3 intron 6) Grouped by Various Characteristics
Figure 2
Figure 2. Meta-Analysis of Studies of GSTM1 Polymorphism and Lung Cancer
The horizontal axis is plotted on a log doubling scale.
Figure 3
Figure 3. Meta-Analysis of Studies of GSTT1 Polymorphism and Lung Cancer
The horizontal axis is plotted on a log doubling scale.
Figure 4
Figure 4. Meta-Analysis of Studies of GSTP1 I105V Polymorphism and Lung Cancer
The horizontal axis is plotted on a log doubling scale.
Figure 5
Figure 5. Meta-Analysis of Studies of GSTP1 A114V and GSTM3 Intron 6 Polymorphisms and Lung Cancer
The horizontal axis is plotted on a log doubling scale.

Similar articles

Cited by

References

    1. Ketterer B. Protective role of glutathione and glutathione transferases in mutagenesis and carcinogenesis. Mutat Res. 1988;202:343–361. - PubMed
    1. Ketterer B, Harris JM, Talaska G, Meyer DJ, Pemble SE, et al. The human glutathione S-transferase supergene family, its polymorphism, and its effects on susceptibility to lung cancer. Environ Health Perspect. 1992;98:87–94. - PMC - PubMed
    1. Hirvonen A. Polymorphisms of xenobiotic-metabolizing enzymes and susceptibility to cancer. Environ Health Perspect. 1999;107(Suppl 1):37–47. - PMC - PubMed
    1. Kato S, Browman ED, Harrigan AM, Blomke B, Shields PG. Human lung carcinogen-DNA adduct levels mediated by genetic polymorphism in vivo. J Natl Cancer Inst. 1995;87:902–907. - PubMed
    1. Rebbeck TR. Molecular epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility . Cancer Epidemiol Biomarkers Prev. 1997;6:733–743. - PubMed

Publication types